BeiGene BGNE HKEX: 06160, SSE: 688235))), a worldwide biotechnology firm right this moment introduced that the Firm will take part within the J.P. Morgan forty first Annual Healthcare Convention on Monday, January 9, 2023 at 1:30 p.m. PT.
A dwell webcast might be accessed from the traders part of BeiGene’s web site at http://ir.beigene.com. An archived replay might be obtainable for 90 days following the occasion.
BeiGene is a worldwide biotechnology firm that’s creating and commercializing modern and inexpensive oncology medicines to enhance remedy outcomes and entry for much extra sufferers worldwide. With a broad portfolio, we’re expediting improvement of our numerous pipeline of novel therapeutics by means of our inner capabilities and collaborations. We’re dedicated to radically enhancing entry to medicines for much extra sufferers who want them. Our rising international crew of greater than 9,000 colleagues spans 5 continents, with administrative workplaces in Cambridge, U.S., & Basel, Switzerland & Beijing, China. To study extra about BeiGene, please go to www.beigene.com and observe us on Twitter at @BeiGeneGlobal.
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20230104005542/en/